439 related articles for article (PubMed ID: 16786576)
1. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
2. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
[TBL] [Abstract][Full Text] [Related]
3. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
[TBL] [Abstract][Full Text] [Related]
4. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
[TBL] [Abstract][Full Text] [Related]
6. Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106-126.
Sassoon J; Daniels M; Brown DR
Mol Cell Neurosci; 2004 Jan; 25(1):181-91. PubMed ID: 14962751
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage.
Jeong JK; Seo JS; Moon MH; Lee YJ; Seol JW; Park SY
Neurobiol Aging; 2012 May; 33(5):1006.e1-10. PubMed ID: 22036844
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxicity of the putative transmembrane domain of the prion protein.
Haïk S; Peyrin JM; Lins L; Rosseneu MY; Brasseur R; Langeveld JP; Tagliavini F; Deslys JP; Lasmézas C; Dormont D
Neurobiol Dis; 2000 Dec; 7(6 Pt B):644-56. PubMed ID: 11114262
[TBL] [Abstract][Full Text] [Related]
9. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
10. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
11. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
12. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
13. Cellular prion protein overexpression disturbs cellular homeostasis in SH-SY5Y neuroblastoma cells but does not alter p53 expression: a proteomic study.
Weiss E; Ramljak S; Asif AR; Ciesielczyk B; Schmitz M; Gawinecka J; Schulz-Schaeffer W; Behrens C; Zerr I
Neuroscience; 2010 Sep; 169(4):1640-50. PubMed ID: 20547212
[TBL] [Abstract][Full Text] [Related]
14. Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis.
Sunyach C; Checler F
J Neurochem; 2005 Mar; 92(6):1399-407. PubMed ID: 15748158
[TBL] [Abstract][Full Text] [Related]
15. Prion peptide-mediated cellular prion protein overexpression and neuronal cell death can be blocked by aspirin treatment.
Jeong JK; Moon MH; Seol JW; Seo JS; Lee YJ; Park SY
Int J Mol Med; 2011 May; 27(5):689-93. PubMed ID: 21347512
[TBL] [Abstract][Full Text] [Related]
16. Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3.
Pérez M; Rojo AI; Wandosell F; Díaz-Nido J; Avila J
Biochem J; 2003 May; 372(Pt 1):129-36. PubMed ID: 12578563
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxic prion protein (PrP) fragment 106-126 requires the N-terminal half of the hydrophobic region of PrP in the PrP-deficient neuronal cell line.
Sakudo A; Nakamura I; Lee DC; Saeki K; Ikuta K; Onodera T
Protein Pept Lett; 2007; 14(1):1-6. PubMed ID: 17266643
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the 106-126 prion peptide with lipid membranes and potential implication for neurotoxicity.
Dupiereux I; Zorzi W; Lins L; Brasseur R; Colson P; Heinen E; Elmoualij B
Biochem Biophys Res Commun; 2005 Jun; 331(4):894-901. PubMed ID: 15882962
[TBL] [Abstract][Full Text] [Related]
20. Prion and doppel proteins bind to granule cells of the cerebellum.
Legname G; Nelken P; Guan Z; Kanyo ZF; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16285-90. PubMed ID: 12446843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
